The Wide and Unpredictable Scope of Synthetic Cannabinoids ToxicityReport as inadecuate

The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity - Download this document for free, or read online. Document in PDF available to download.

Case Reports in Critical CareVolume 2015 2015, Article ID 542490, 5 pages

Case ReportDepartment of Medicine, New York University School of Medicine, Woodhull Medical and Mental Health Center, 760 Broadway, Brooklyn, NY 11206, USA

Received 27 September 2015; Revised 1 December 2015; Accepted 2 December 2015

Academic Editor: Chiara Lazzeri

Copyright © 2015 Jose Orsini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Drug use and abuse continue to be a large public health concern worldwide. Over the past decade, novel or atypical drugs have emerged and become increasingly popular. In the recent past, compounds similar to tetrahydrocannabinoid THC, the active ingredient of marijuana, have been synthetically produced and offered commercially as legal substances. Since the initial communications of their abuse in 2008, few case reports have been published illustrating the misuse of these substances with signs and symptoms of intoxication. Even though synthetic cannabinoids have been restricted, they are still readily available across USA and their use has been dramatically increasing, with a concomitant increment in reports to poison control centers and emergency department ED visits. We describe a case of acute hypoxemic-hypercapnic respiratory failure as a consequence of acute congestive heart failure CHF developed from myocardial stunning resulting from a non-ST-segment elevation myocardial infarction MI following the consumption of synthetic cannabinoids.

Author: Jose Orsini, Christa Blaak, Eric Tam, Salil Rajayer, Joaquin Morante, Angela Yeh, and Ashvin Butala



Related documents